FTC Requests Additional Info On $16.5B Novo-Catalent Deal

By Tom Zanki · May 3, 2024, 4:46 PM EDT

The Federal Trade Commission is seeking additional information on Novo Holdings' planned $16.5 billion acquisition of pharmaceutical services company Catalent in order to examine whether the blockbuster deal passes antitrust muster,...

To view the full article, register now.